Myocardial contrast agents: recent advances and future directions

Area of Science:

• Cardiovascular Imaging
• Biomedical Engineering
• Diagnostic Ultrasound

Background:

• Myocardial contrast echocardiography (MCE) has advanced significantly from early contrast agents.
• First-generation agents (air-based) had limitations in microbubble persistence and opacification.
• Second-generation agents offer improved properties for better perfusion assessment.

Purpose of the Study:

• To review the evolution and current state of myocardial contrast agents for echocardiography.
• To discuss the composition, properties, and acoustic characteristics of MCE agents.
• To explore novel applications and clinical trials of microbubble technology.

Main Methods:

• Review of existing literature on myocardial contrast echocardiography agents.
• Analysis of the physical and acoustic properties of first- and second-generation contrast agents.
• Discussion of innovative imaging techniques like harmonic and triggered imaging.

Main Results:

• Second-generation agents possess higher molecular weight, lower solubility, and reduced diffusivity, enhancing microbubble persistence.
• These agents achieve transpulmonary passage, opacifying left-heart chambers and myocardial microcirculation.
• Advanced imaging techniques improve signal-to-noise ratio for clearer perfusion assessment.

Conclusions:

• Modern contrast agents and imaging techniques have revolutionized myocardial perfusion assessment.
• Microbubble technology is expanding into novel therapeutic and diagnostic applications.
• Ongoing clinical trials continue to validate and expand the use of these agents.